UK Markets closed

Santhera Pharmaceuticals Holding AG (0QN1.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
0.8815+0.0255 (+2.98%)
At close: 05:25PM GMT
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.8815
52-week low 30.8815
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 56.44M
Implied shares outstanding 6N/A
Float 824.56M
% held by insiders 111.68%
% held by institutions 13.70%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021


Profit margin 0.00%
Operating margin (ttm)3,566.65%

Management effectiveness

Return on assets (ttm)-39.55%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)-1.59M
Revenue per share (ttm)-0.05
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-5.36M
EBITDA -53.59M
Net income avi to common (ttm)-55.53M
Diluted EPS (ttm)-2.1210
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)21.21M
Total cash per share (mrq)0.43
Total debt (mrq)42.98M
Total debt/equity (mrq)3,236.14
Current ratio (mrq)0.75
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-37.36M
Levered free cash flow (ttm)-38.37M